Chartwell Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Chartwell Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$6.31M	Sell
2024 Q2	$6.42M	Buy
2024 Q1	$4.11M	Sell
2023 Q4	$3.86M	Buy
2023 Q3	$2.54M	Sell
2023 Q2	$2.28M	Buy
2023 Q1	$1.6M	Buy